TauroPharm GmbH

TauroPharm GmbH specializes in sterile medical sets primarily used for intravenous therapy. Their products include hanging sets for central venous catheters (ZVK) and port systems, as well as completion sets for intravenous nutrition therapy and total parenteral nutrition (TPN). Many of these sets incorporate added saline (NaCl) for flushing or priming purposes, such as the APOSAN and WB Simple & Safe lines, which are designed for specific clinical applications like catheter lock solutions and infusion therapy.

TauroPharm GmbH is headquartered in Germany. The company’s location in Germany aligns with European regulatory frameworks, ensuring compliance with EU medical device standards and requirements.

TauroPharm GmbH’s devices are registered in the eudamed database, which is the official EU portal for medical device information under the European Medical Device Regulation (MDR). This registry ensures transparency and traceability of devices authorized for use within the European Economic Area.

TauroPharm GmbH’s devices fall into Class IIa, Class IIb, and Class III classifications under EU medical device regulations. These classifications are determined by risk levels: Class III devices pose the highest risk (e.g., those directly supporting life or involving long-term implantation), while Class IIa and IIb devices carry moderate or lower risks. The classification influences the regulatory scrutiny and documentation requirements for each product.